Trial Profile
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Feb 2020
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; MEDI 3250 (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms SLVP030
- 03 Apr 2019 Status changed from recruiting to completed.
- 08 Mar 2018 New trial record